From Men's Health · Korin Miller · · 1m 10s
TL;DR: FDA Warns GLP-1 Users About Vision Risk
FDA flags rare vision loss risk for GLP-1 medication users.
FDA warns GLP-1 drugs may cause permanent vision loss in rare cases but stress risk remains extremely low. FDA flags rare vision loss risk for GLP-1 medication users. The FDA released a drug safety communication warning about potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) for GLP-1 medication users.
- FDA Drug Warning
- What is NAION?
- FDA's Warning Details
- Expert Opinions
Read the story version — the same reporting as a swipeable deck of 7 cards.






